according to the national institute of Healthcare management,between 1989 and 2000 the U.S. food and drug approved 1035 new drug applications-of these ,65 percent contained active ingredients that were already on the market(incrementally modified drugs),11 percent were identical and only 15 percent were considered a "highly innovative drug." mischief like this is more evident in genetic engineering of SEEDS.the MNCs modify or introduce a gene and patent the whole seed,which contain thousands of genes.who is the owner of other genes in the seed?
according to the national institute of Healthcare management,between 1989 and 2000 the U.S. food and drug approved 1035 new drug applications-of these ,65 percent contained active ingredients that were already on the market(incrementally modified drugs),11 percent were identical and only 15 percent were considered a "highly innovative drug."
ReplyDeletemischief like this is more evident in genetic engineering of SEEDS.the MNCs modify or introduce a gene and patent the whole seed,which contain thousands of genes.who is the owner of other genes in the seed?